Logo
  • About
  • Contact
  • (888) 441-8033

hC Bioscience to Present at Locust Walk RNA Innovation Conference

Cambridge, MA – May 2, 20223 -- hC Bioscience (Private) announced that Leslie Williams, president and CEO, will deliver a presentation on the science behind tRNA-based therapies and the company's therapeutic programs at the Locust Walk RNA Innovation Conference on Tuesday, May...

View full release

GaN Systems to Showcase the Power of GaN at Data Center World 2023

OTTAWA, Canada – May 2, 2023 – GaN Systems, the global leader in GaN (gallium nitride) power semiconductors, today announced that it will be exhibiting innovative GaN solutions and presenting “Efficiency and Profitability in the Data Center with GaN” at Data Center World, the ...

View full release

Stonegate Capital Partners Updates Coverage on Civeo Corporation (NYSE: CVEO) 2023 Q1

DALLAS, TX -- May 1st, 2023 --  Civeo Corporation (NYSE: CVEO): Stonegate Capital Partners initiates their coverage on Civeo Corporation. The full report can be accessed by clicking on the following link: Civeo Q1 2023 Report COMPANY UPDATES Significant Free Cash Flow Generat...

View full release

Stonegate Capital Partners Updates Coverage On Plumas Bancorp (Nasdaq: PLBC) 23 Q1

DALLAS, TX -- April 28th, 2023 -- Plumas Bancorp (Nasdaq: PLBC): Stonegate Capital Partners updates coverage on Plumas Bancorp (Nasdaq: PLBC). The full report can be accessed by clicking on the following link: Plumas Bancorp 2023 Q1 Report Company Summary Continued growth: As...

View full release

Kiora's Investigational Treatment for Retinitis Pigmentosa, KIO-301, Demonstrates Visual Function Restoration in Patients Who Are Blind

Encinitas, California, April 27, 2023 – Kiora Pharmaceuticals (NASDAQ: KPRX) presented preliminary results from an ongoing clinical trial showing its investigational drug, KIO-301, has the potential to restore light perception in patients who are blind or living with ultra-low...

View full release

Stonegate Capital Partners Updates Coverage On Plumas Bancorp (Nasdaq: PLBC) 2023 Q1

DALLAS, TX -- April 27th, 2023 -- Plumas Bancorp (Nasdaq: PLBC): Stonegate Capital Partners updates coverage on Plumas Bancorp (Nasdaq: PLBC). The full report can be accessed by clicking on the following link: Plumas Bancorp 2023 Q1 Report Company Summary Continued growth: A...

View full release

Reportable Launches Reportabot, An AI-Powered Tool to Generate News Releases in Under 60 Seconds

April 27, 2023 - Reportable today launched Reportabot, an AI-based tool that writes news releases in under 60 seconds with minimal input. The free tool will help time-strapped entrepreneurs, businesses, and communications professionals quickly create the first draft of an anno...

View full release

BOSTON REALTY ADVISORS AND ADVISORS LIVING: ‘IT’S ABOUT OUR PEOPLE’

BOSTON –Boston Realty Advisors, the largest independent real estate services firm in Massachusetts, and its affiliated residential sales platform Advisors Living today proclaimed “It’s About Our People” as their new common tagline, reflecting the companies’ long and continuing...

View full release

Stonegate Capital Partners Updates Coverage On Aemetis, Inc. (Nasdaq: AMTX) Q4 2022

DALLAS, TX -- April 25th, 2023 -- Aemetis, Inc. (Nasdaq:AMTX): Stonegate Capital Partners updates coverage on Aemetis, Inc. (Nasdaq:AMTX). The full report can be accessed by clicking on the following link: https://stonegateinc.com/reports/AMTX_22Q4.pdf Company Summary 5-year...

View full release

Fe Pharmaceuticals Closes SEED Investment and Names Robert Klein to the Board of Directors

April 25, 2023, Redwood City, CA, USA- Fe Pharmaceuticals has raised a SEED investment to continue developing DIBI, a non-toxic, iron-binding copolymer, as a potent, broad-spectrum, antimicrobial agent active against bacterial and fungal infections, including drug-resistant or...

View full release
  • « First
  • ‹ Prev
  • …
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • …
  • Next ›
  • Last »
©2025 Reportable, Inc.
Terms and Conditions | Privacy Policy